Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion type Assertion NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_head.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion description "[Trastuzumab is considered effective against human epidermal growth factor receptor (HER)-2-positive breast cancer as assessed by immunohistochemistry (IHC) and fluorescence or chromogenic in situ hybridization (FISH/CISH) on biopsy material.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion evidence source_evidence_literature NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion SIO_000772 18448549 NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion wasDerivedFrom befree-2016 NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.
- NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_assertion wasGeneratedBy ECO_0000203 NP668690.RAGQntQpCuE0zUKHzzou-skQEBM6JRGVyj2Wapd0MRimg130_provenance.